Malissa Carroll, Author at NFCR

Malissa Carroll

Cancer Patients and the Flu: What You Need to Know

The COVID-19 pandemic has not replaced the risks posed by the seasonal flu. Learn why the influenza virus is particularly dangerous for cancer patients and how to keep yourself and your loved ones safe.  With so much attention focused on the ongoing COVID-19 pandemic, it can be easy for us…...

Read more

Biosimilar Drugs: Lowering the Cost of Cancer Care?

The National Foundation for Cancer Research (NFCR) answers some of the most frequently asked questions about biosimilar drugs for cancer treatment. Biologic drugs (biologics) are a special class of medications that are made from living organisms, such as proteins.1 Vaccines, hormones, and anti-allergy medications are all examples of biologics.2 These…...

Read more

Family Health History: Talk with Your Loved Ones This Holiday Season

From marriage proposals to politics, many topics are discussed around the holiday dinner table. This year, make sure to talk with your loved ones about your family health history to help better understand your unique health risks. The holiday season is approaching. As you get together with loved ones —…...

Read more

NFCR-Supported Researcher Leads Study Aiming to Understand Which Patients May Respond Best to Immunotherapy

New approach developed by Dr. Rakesh Jain and his research team identifies biomarkers that may indicate which patients will best respond to immune checkpoint blockade therapies. A research team led by NFCR-supported scientist Rakesh K. Jain, PhD, the Andrew Werk Cook Professor of Tumor Biology at Harvard Medical School and…...

Read more

FDA Recalls Popular Heartburn Drug Ranitidine: What You Need to Know

Medication commonly used to treat acid reflux and GERD pulled from the market after scientists find concerning levels of a potential cancer-causing substance in the drug. In April, the U.S. Food and Drug Administration (FDA) requested that all medications containing ranitidine be pulled from the market after an ongoing investigation…...

Read more

Stomach Cancer Warning Signs: Understanding Your Risk

Stomach cancer is frequently diagnosed at an advanced stage because early symptoms are vague and often go overlooked. Learn what symptoms to watch for and steps you can take to help lower your risk. November is Stomach Cancer Awareness Month. Stomach cancer — also known as gastric cancer — is…...

Read more

Mastectomy and Breast Reconstruction: What Breast Cancer Patients Should Know

Mastectomy is just one of the treatment options available to breast cancer patients. Learn more about what to expect before, during, and after the procedure, as well as some tips to help you prepare. A breast cancer diagnosis can be devastating, and navigating potential treatment options can be stressful and…...

Read more

How Artificial Intelligence is Aiding Advances in Prostate Cancer Detection

New studies showcase how researchers around the world are leveraging machine learning to aid pathologists in detecting prostate cancer. Artificial intelligence (AI) refers to the use of “smart” machines to complete tasks that usually require human intelligence. Although it has applications in many fields, its use in health care has…...

Read more

Researchers Uncover Causal Link Between HPV and Prostate Cancer

Presence of human papilloma viruses (HPVs) in prostate tumors suggests countries should encourage universal vaccination against HPV infections. A literature review published by James Lawson and Wendy Glenn from the University of New South Wales in Australia suggests human papilloma viruses (HPVs) may have a causal role in prostate cancer.…...

Read more

Genetic Testing: Learning More About Your Cancer Risk

Genetic testing can be an important tool in helping patients learn about their inherited cancer risk, but the results are not always as clear as patients might expect. Just as traits such as hair color and eye color can be passed down from parents to their children, so too can…...

Read more